Understanding The Real Cost Difference Between These Weight Loss Treatments
Price Comparison: Mounjaro vs Wegovy Treatment Costs in the UK
The difference between Mounjaro and Wegovy extends beyond their clinical mechanisms to their pricing structures across UK pharmacies. Wegovy's dose escalation starts at 0.25mg for £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance dose of 2.4mg (£209.99). These prices include your clinical assessment, prescriber review, and next-day delivery from our GPhC-registered pharmacy (#9012878). Mounjaro follows a different pricing structure due to its dual-action mechanism, though both treatments require the same rigorous prescription process.
When evaluating the difference between Mounjaro and Wegovy costs, consider the long-term treatment duration rather than just initial pricing. New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25 to access these competitive rates. Our bundle options, such as the Intro Trio (0.25mg, 0.5mg, and 1mg) for £299.99, provide convenient multi-month supplies. Both treatments represent prescription-only medicines requiring ongoing clinical supervision, making transparent pricing essential for informed decision-making.
Clinical Mechanisms: How Mounjaro and Wegovy Work Differently
The fundamental difference between Mounjaro and Wegovy lies in their active ingredients and receptor targeting mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1, reducing appetite and promoting satiety after smaller meals. This mechanism works primarily through brain appetite centres, potentially reducing food cravings and supporting portion control. Clinical trials, including the STEP programme, demonstrated that patients taking Wegovy alongside diet and exercise achieved average weight reductions of approximately 15% at 68 weeks (Wilding et al., NEJM, 2021).
Mounjaro's active ingredient, tirzepatide, represents a dual-action approach targeting both GIP and GLP-1 receptors simultaneously. This broader mechanism may influence glucose regulation and appetite control through multiple pathways, though both treatments require combination with a reduced-calorie diet and increased physical activity. The difference between Mounjaro and Wegovy mechanisms means they may suit different patient profiles, which is why our clinical assessment evaluates your individual circumstances before recommendation.
Understanding Wegovy's GLP-1 Mechanism and Clinical Benefits
Wegovy functions as a once-weekly GLP-1 receptor agonist, designed to mimic your body's natural fullness signals more effectively than diet and exercise alone. The medication works by binding to GLP-1 receptors in your brain's appetite control centres, potentially reducing hunger sensations and increasing feelings of satisfaction after eating smaller portions. This mechanism may help break the cycle of overeating by supporting your natural satiety responses. Unlike stimulant-based appetite suppressants, Wegovy works with your body's existing hormone pathways to promote sustainable eating pattern changes. The prescription-only medicine must be combined with lifestyle modifications to achieve optimal results, as demonstrated in clinical trials where participants followed structured diet and exercise programmes.
EverydayMeds Ordering Process: From Assessment to Delivery
Our streamlined process eliminates the complexity often associated with accessing prescription weight management treatments while maintaining clinical safety standards. Begin with our 3-minute online clinical assessment, covering your medical history, current medications, and weight management goals to ensure Wegovy or Mounjaro suitability. Your application receives review from our qualified prescribers within 3 working days (or 24 hours with express service), ensuring thorough clinical oversight. Once approved, your prescription-only medicine ships via temperature-controlled next-day delivery, maintaining the cold-chain integrity essential for these injectable treatments. This comprehensive service, from assessment through delivery, is included in our transparent pricing structure without additional consultation fees.
Storage and Practical Considerations: Wegovy vs Mounjaro Differences
Storage requirements highlight another practical difference between Mounjaro and Wegovy for UK patients managing treatment logistics. Wegovy offers superior travel flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both treatments require initial refrigerated storage at 2-8°C before first use, using similar FlexTouch pen delivery systems. Wegovy's dose escalation follows a structured 16-week progression (0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance), while Mounjaro uses different incremental steps. This storage advantage makes Wegovy particularly suitable for patients with active lifestyles or irregular schedules who may need extended room temperature storage periods.
Bundle Value Analysis: Maximising Your Mounjaro vs Wegovy Investment
When comparing the difference between Mounjaro and Wegovy treatment costs, bundle purchasing provides significant practical advantages beyond individual pen pricing. Our Getting Started bundles, such as the Progress Duo (0.5mg and 1mg for £189.99), ensure seamless dose escalation without reordering interruptions. The Consistency bundles offer maintenance dose supplies, with the 2.4mg Consistency bundle (two pens) priced at £419.99 for extended treatment continuity. These bundle options eliminate the risk of treatment gaps that could compromise your weight management progress.
The difference between Mounjaro and Wegovy bundle strategies reflects their distinct escalation schedules and maintenance requirements. Consider the Ultimate Stability Trio (three 2.4mg pens for £649.99) if you've established successful maintenance dosing, providing three months of uninterrupted supply. Bundle purchasing also reduces delivery frequency and associated logistics, particularly valuable for patients managing busy schedules or those preferring discrete, less frequent deliveries of their prescription medication.
Making Your Choice: Clinical Factors Beyond Price Comparison
While cost considerations are important, the difference between Mounjaro and Wegovy should primarily be evaluated based on clinical suitability for your individual circumstances. Both treatments require BMI ≥30 (or ≥27 with weight-related comorbidities) and represent long-term weight management commitments rather than short-term solutions. Your medical history, current medications, and previous treatment responses influence which option our prescribers may recommend during clinical assessment. NICE guidance (TA875) emphasises the importance of specialist weight management support alongside these medications, which our clinical team provides throughout your treatment journey.
The decision between these prescription-only medicines shouldn't be based solely on initial pricing, as treatment duration typically extends beyond the dose escalation period into long-term maintenance. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which treatment aligns best with your clinical profile and lifestyle requirements. Our clinical team maintains ongoing support to optimise treatment outcomes and address any questions about your chosen therapy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
